Market Tracker

03/27 6:01pm ET

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

54.85
Delayed Data
As of Mar 27
 +2.08 / +3.94%
Today’s Change
13.19
Today|||52-Week Range
58.08
+70.08%
Year-to-Date

Today’s Trading

Previous close52.77
Today’s open53.04
Day’s range52.79 - 55.53
Volume537,725
Average volume (3 months)566,412
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+19.26%
Earnings growth (next 5 years)+63.40%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.32-0.49%
CLVSClovis Oncology Inc+1.23+1.70%
CBPOChina Biologic Produ...+3.92+4.49%
ASPXAuspex Pharmaceutica...+2.07+3.01%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Senior Vice President
Geoffrey M. Parker
Corporate headquarters
Palo Alto, California

Forecasts